Purple Biotech (PPBT) Property, Plant & Equipment (Net) Growth (3y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -14.40% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -9.89% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 10.71% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -0.31% |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -16.76% |
| Sep 30, 2025 | -17.84% |
| Jun 30, 2025 | -17.10% |
| Mar 31, 2025 | -27.06% |
| Dec 31, 2024 | -23.50% |
| Sep 30, 2024 | -23.34% |
| Jun 30, 2024 | -25.08% |
| Mar 31, 2024 | -12.43% |
| Dec 31, 2023 | -4.71% |
| Jun 30, 2023 | 75.70% |
| Dec 31, 2022 | 78.19% |
| Jun 30, 2022 | 80.95% |
| Dec 31, 2021 | 95.63% |
| Jun 30, 2021 | 111.29% |
| Dec 31, 2020 | 85.25% |
| Jun 30, 2020 | 18.17% |
| Dec 31, 2019 | 33.42% |
| Jun 30, 2019 | 53.78% |
| Dec 31, 2018 | 66.61% |